Home › NCT07395622
EpiFaith Resident Learning Curve Trial
Impact of the EpiFaith® Syringe on the Learning Curve of Anesthesia Residents for the Labor Epidural Technique: A Quasi-Experimental Study
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Anesthesiology residents with fewer than 5 prior epidural placement experiences Exclusion Criteria: * anesthesiology residents with more than 5 prior epidural placement experiences
About the study
This study aims to evaluate the impact of the EpiFaith® syringe on the learning curve of anesthesia residents for the labor epidural technique. Anesthesia residents with prior experience placing \< 5 labor epidurals will be enrolled. Their performance of 20 sequential labor epidural placements with either standard technique with a beveled glass syringe or the EpiFaith® syringe will be observed. Successful epidural placement over time with sequential epidural placement attempts will be measured between groups. The primary outcome will be rate of successful epidural placement. Success will be defined as a composite of 4 criteria: maximum 3 attempts for placement; no need to re-site at a different level; no required intervention by the supervising attending anesthesiologist; and adequate analgesia with a visual analog score (VAS) \<3 at 30 minutes. We hypothesize that use of the EpiFaith® syringe will enable a faster learning curve for successful epidural placement. A cumulative sum chart (CUSUM) analysis will evaluate whether the EpiFaith® syringe causes deviation from the control learning curve. Secondary outcomes will include rate of inadvertent dural puncture and epidural replacement rate.
What is being tested
- EpiFaith epidural syringe (device)
- Control (glass) syringe (device)
Sponsor: Brigham and Women's Hospital · Participants: 34 · Started: Sep 1, 2023
Contact the study team
- Michaela K Farber, MD MS · Phone: 617-759-1609
- Noor A Raheel, MD · Phone: 617-732-8251
Official record on ClinicalTrials.gov — NCT07395622
Locations in the U.S.
| Massachusetts | Brigham and Women's Hospital, Boston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.